Navigation Links
Nelnet Delays Earnings Announcement
Date:3/1/2009

LINCOLN, Neb., March 1 /PRNewswire-FirstCall/ -- Nelnet, Inc. (NYSE: NNI) announced today that it is delaying the release of its 2008 year-end results as the company's independent external auditor completes its review of the valuation of the company's derivative portfolio, which is excluded from base net income. The company previously announced it would issue an earnings release before market open on March 2, 2009. Depending on the timing of the completion of the review, the company may also reschedule its earnings conference call currently scheduled for the afternoon of March 3, 2009.

For more than 30 years, Nelnet has been helping families plan, prepare, and pay for their education. Additional information is available at http://www.nelnet.com.


    (code #: nnif)


'/>"/>
SOURCE Nelnet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Study finds pregnancy has no impact on breast cancer survival, delays treatment, diagnosis
2. Women May Be More Likely to Experience EMS Delays for Heart Care
3. Women With Heart Attack Symptoms See Delays in Care
4. Delays in radiation therapy lead to increased breast cancer recurrence
5. Brains Magnetic Fields Reveal Language Delays in Autism
6. Historic Lawsuit Challenges Unacceptable Delays in Delivering Benefits to Americas Veterans by Department of Veterans Affairs
7. Historic Legislation to End Delays in Veterans Health Care Funding
8. Kings County Death: NAMI Calls for Criminal Probe; Survey Shows Psychiatric Emergency Room Delays Are National Problem
9. Teenagers and young adults with cancer can face long delays before finally being diagnosed
10. Allied Healthcare Net Falls on Manufacturing Delays
11. Infantile esotropia linked to developmental delays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company ... NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic ... organizations that have excellent programs for the delivery and improvement of disease management ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... solution that enables organizations to easily reprint customer invoices, bills, statements and other ... all of the steps needed to retrieve and print the documents and batch ...
(Date:3/23/2017)... ... 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... VoiceAmerica, recently talked on her program about how she is looking forward to World ... of an important distinction. World Water Day, Kleyne pointed out, is an occasion for ...
(Date:3/23/2017)... El Segundo, CA (PRWEB) , ... March 23, ... ... Verisys FACIS Monthly Monitoring Healthcare products at competitive pricing. ... primary source sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 — ... the new EU MDR language change the way manufacturers approach CERs? , ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... COPENHAGEN, Denmark , March 23, 2017 ... utilizes its innovative TransCon technology to address significant unmet ... company will host a conference call and webcast on ... of the Endocrine Society in Orlando, Florida ... rare disease pipeline candidates (TransCon Growth Hormone, TransCon PTH ...
(Date:3/23/2017)... 23, 2017 Prima BioMed has ... trial of IMP321 in combination with Keytruda, with one ... cohort experiencing a complete response. Recruitment in the second ... to be fully recruited by Q317. Preliminary efficacy data ... cancer study are expected mid-year (recruitment in the 226-patient ...
(Date:3/23/2017)... 2017 Piramal Pharma Solutions ... el nombramiento de Stuart E. Needleman ... servicios integrados completa para su base de clientes ... en el crecimiento y ejecución de las ofertas ... impulsar todas las actividades de desarrollo empresarial global ...
Breaking Medicine Technology: